Echo Therapeutics (ECTE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2000 | 03-2000 | 12-1999 | 09-1999 | 06-1999 | |
| Sales | 7 | 90 | -8,065 | 2,936 | 2,719 |
| Cost of Goods | 5 | 60 | -3,680 | 1,260 | 1,250 |
| Gross Profit | 2 | 20 | -4,375 | 1,670 | 1,460 |
| Operating Expenses | 455 | 340 | -4,280 | 1,680 | 1,470 |
| Operating Income | -448 | -250 | -785 | 256 | 249 |
| Interest Expense | 0 | 0 | -360 | 130 | 120 |
| Other Income | 118 | 90 | 205 | -86 | -59 |
| Pre-tax Income | -330 | -160 | -220 | 40 | 70 |
| Income Tax | 0 | 0 | -30 | 20 | 30 |
| Net Income Continuous | -336 | -160 | -140 | 26 | 40 |
| Net Income Discontinuous | 0 | 0 | 160 | 0 | 0 |
| Net Income | $-336 | $-160 | $20 | $26 | $40 |
| EPS Basic Total Ops | -1.00 | -0.50 | N/A | 1.00 | 1.00 |
| EPS Basic Continuous Ops | -0.96 | -0.54 | N/A | 0.89 | 1.37 |
| EPS Diluted Total Ops | -1.00 | -0.50 | N/A | 1.00 | 1.00 |
| EPS Diluted Continuous Ops | -0.96 | -0.54 | N/A | 0.89 | 1.37 |
| EBITDA(a) | $-320 | $-248 | $-455 | $606 | $609 |